Transfusions have been used as a life-saving modality for hundreds of years. The first
documented transfusion in any species occurred in 1665 when Richard Lower withdrew …

This review summarises the current understanding of immune response and T cell subsets
in the context of development of autoimmunity in the dog. Mode of action and rational usage …

Immune‐mediated hemolytic anemia (IMHA) causes severe anemia in dogs and is
associated with considerable morbidity and mortality. Treatment with various …

Objectives Thrombosis is a well‐recognized phenomenon in dogs and cats with a significant
impact on morbidity and mortality. Despite growing awareness of thrombosis and increased …

The body's immune system is essential for protecting it from a variety of pathogens and other
external insults. It is through the complex interactions between the cells and mediators of …

Objective—To evaluate whole blood hemostasis by means of thromboelastography in dogs
with primary immune-mediated hemolytic anemia (IMHA) to determine whether these dogs …

Idiopathic immune-mediated haemolytic anaemia (IMHA) is one of the most common
immune-mediated diseases of dogs. The aim of this article is to review current knowledge of …

Despite being the most prevalent autoimmune disease of dogs, there is considerable
variation between individuals and institutions in the treatment regimens that are employed …

Objective To compare short‐term outcome and frequency of adverse events for dogs with
idiopathic immune‐mediated haemolytic anaemia treated with glucocorticoids and …

Objective To review the pathophysiology of thrombosis in hemolytic disease, and the
efficacy of thromboprophylaxis in dogs with immune‐mediated hemolytic anemia (IMHA) …